Human Kallikrein 3/PSA Antibody, R&D Systems™

Kallikrein 3/PSA

Monoclonal

LYOPH

Neutralization 21 ug/mL

NP_001639

KLK3

Mouse myeloma cell line NS0-derived recombinant human Kallikrein 3/PSA Pro19-Pro261 Accession # NP_001639

25 μg

Primary

Detects human Kallikrein 3/PSA in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) Factor X, rhHGF-A, rhKLK-4, -5, -8, -11, or rhThrombin is observed.

Human

Purified

Neutralization

181827

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

APS seminin, EC 3.4.21, EC 3.4.21.77, Gamma-seminoprotein, hK3, kallikrein 3, (prostate specific antigen), Kallikrein-3, kallikrein-related peptidase 3, KLK2A1, KLK3, P-30 antigen, prostate specific antigen, prostate-specific antigen, PSA, PSA semenogelase, Semenogelase, Seminin

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

354

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2b